These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 13730599)
21. ELECTROMYOGRAM IN MUSCULAR DYSTROPHY. WITH PARTICULAR REFERENCE TO DIFFERENTIAL DIAGNOSIS BETWEEN THIS DISEASE AND OTHER NEUROMUSCULAR DISORDERS. MARINACCI AA Bull Los Angel Neuro Soc; 1964 Mar; 29():7-16. PubMed ID: 14129457 [No Abstract] [Full Text] [Related]
23. [Creatine phosphokinase in the diagnosis of myocardial infarction and myopathies]. FORSTER G; ESCHER J Helv Med Acta; 1961 Sep; 28():513-9. PubMed ID: 13894149 [No Abstract] [Full Text] [Related]
24. SERUM ENZYME STUDIES IN MUSCLE DISEASE. II. SERUM CREATINE KINASE ACTIVITY IN MUSCULAR DYSTROPHY AND IN OTHER MYOPATHIC AND NEUROPATHIC DISORDERS. PEARCE JM; PENNINGTON RJ; WALTON JN J Neurol Neurosurg Psychiatry; 1964 Apr; 27(2):96-9. PubMed ID: 14167093 [No Abstract] [Full Text] [Related]
25. [DETERMINATION OF CREATINE PHOSPHOKINASE IN THE BLOOD SERUM OF PATIENTS WITH PROGRESSIVE MUSCULAR DYSTROPHY]. GRINIO LP; KONSISTORUM AV Vopr Med Khim; 1964; 10():70-3. PubMed ID: 14207496 [No Abstract] [Full Text] [Related]
26. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Perry TB; Fraser FC Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611 [No Abstract] [Full Text] [Related]
28. Demonstration of serum creatine kinase isoenzymes by fluorescence technique. Somer H; Konttinen A Clin Chim Acta; 1972 Aug; 40(1):133-8. PubMed ID: 4115689 [No Abstract] [Full Text] [Related]
29. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders. Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868 [No Abstract] [Full Text] [Related]
30. [STUDY OF SIDEREMIA IN SUBJECTS WITH PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER RE-METABOLIZING THERAPY]. BUSCAINO GA; SPADETTA V Acta Neurol (Napoli); 1964; 19():509-22. PubMed ID: 14208395 [No Abstract] [Full Text] [Related]
33. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders. Zweig MH; Adornato B; Van Steirteghem AC; Engel WK Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757 [TBL] [Abstract][Full Text] [Related]
34. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy. Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744 [TBL] [Abstract][Full Text] [Related]
38. STUDIES IN NEUROMUSCULAR DISEASE. I. TOTAL BODY POTASSIUM IN MUSCULAR DYSTROPHY AND RELATED DISEASES. KOSSMANN RJ; PETERSON DC; ANDREWS HL Neurology; 1965 Sep; 15():855-65. PubMed ID: 14334962 [No Abstract] [Full Text] [Related]
39. [On the behavior of creatine-phosphokinase activity in the serum of patients with progressive muscular dystrophy]. CUTILLO S; COLETTA A; REA F; BERNI CANANI M Boll Soc Ital Biol Sper; 1963 Jul; 39():769-72. PubMed ID: 14024396 [No Abstract] [Full Text] [Related]
40. Creatine phosphokinase alterations in neuromuscular diseases. Munsat T Isr J Med Sci; 1977 Feb; 13(2):93-7. PubMed ID: 863695 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]